CMS issues guidance on IMD treatment option for substance use disorders

The Centers for Medicare & Medicaid Services yesterday released for state Medicaid agencies implementing Section 5052 of the SUPPORT for Patients and Communities Act of 2018, which gives states the option to cover substance use disorder treatment and withdrawal management services for adults who reside primarily in an eligible institution for mental diseases. The guidance provides information on the new state plan option, including requirements related to beneficiary and provider eligibility, clinical screenings, continuum of care, care transitions, and maintenance of existing expenditures.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services June 20 announced it is finalizing its 2025 Marketplace Integrity and Affordability final rule. The rule鈥
Headline
A new video in the AHA鈥檚 series 鈥淢edicaid: Real Lives, Real Care鈥 features insight from Leah Blackwell, R.N., vice president and chief nursing officer at鈥
Headline
Coalition ad links decisions on Medicaid cuts by Congress to impacts on hospitalsA new television and digital advertisement launched today by the Coalition to鈥
Perspective
As the Senate eyes a vote next week on its reconciliation bill, the next few days are crucial for reaching out to your senators and urging them to make changes鈥
Headline
The latest video in the AHA鈥檚 series 鈥淢edicaid: Real Lives, Real Care鈥 features Becky Pletzer, a licensed clinical social worker from Alaska, explaining why it鈥
Headline
The Senate Finance Committee June 16 released its draft legislative text as part of the Senate鈥檚 version of the budget reconciliation bill. The committee,鈥